glp-1 reimbursement news The Access Gap: Mapping Who Can Actually Afford America's Miracle Weight-Loss Drugs GLP-1s Are Busting Employer Budgets.

Milliman estimates that a payer with high discontinuation rates may experience a 26% inefficiency in drug spend

Its important to note that there is no standardized GLP-1 microdosing chart or microdosing schedule that applies to everyone

Glucagon-like peptide-1 receptor agonists (arGLP-1) have emerged as a promising adjunctive therapy for managing these suboptimal outcomes

In fact, taking it on a completely empty stomach might actually make you feel a bit more lightheaded or nauseous

Ongoing research is ongoing to explore broader therapeutic applications

Patients should never accelerate the titration schedule without medical guidance, as this may worsen side effects without improving therapeutic outcomes